Search

everythinglearnresearchcommunity

for

Search:↓

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

Abnormal T-cells from thymomas cause non-motor symptoms in some myasthenia gravis patients.

CD4 T cells can cause alopecia areata by activating CD8 T cells to attack hair follicles.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

T-cell patterns in skin help distinguish alopecia areata from androgenetic alopecia.

People with acne have more CD4+ immune cells in their skin than healthy people.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

BTNL2 helps protect hair follicles from immune attacks, which could aid in treating alopecia areata.

Non-immune dermal cells dominate, epidermal cells increase after day 9, and certain immune cells persist beyond inflammation in wound-induced hair follicle regeneration.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.